Acadia Healthcare (NASDAQ:ACHC) Downgraded by Raymond James to “Outperform”

Raymond James downgraded shares of Acadia Healthcare (NASDAQ:ACHC) from a strong-buy rating to an outperform rating in a research note issued to investors on Wednesday morning, BenzingaRatingsTable reports. They currently have $45.00 price target on the stock.

Other equities research analysts have also issued reports about the stock. Deutsche Bank set a $32.00 target price on shares of Acadia Healthcare and gave the stock a hold rating in a research report on Thursday, May 2nd. Mizuho set a $30.00 target price on shares of Acadia Healthcare and gave the stock a hold rating in a research report on Friday, May 31st. BMO Capital Markets boosted their target price on shares of Acadia Healthcare from $33.00 to $36.00 and gave the stock a market perform rating in a research report on Wednesday, May 1st. BidaskClub upgraded shares of Acadia Healthcare from a strong sell rating to a sell rating in a research report on Saturday, July 27th. Finally, TheStreet upgraded shares of Acadia Healthcare from a d+ rating to a c rating in a research report on Monday, June 17th. Two analysts have rated the stock with a sell rating, seven have given a hold rating and four have given a buy rating to the company. The company has an average rating of Hold and a consensus target price of $36.90.

Shares of NASDAQ ACHC opened at $29.07 on Wednesday. The stock has a market cap of $2.62 billion, a price-to-earnings ratio of 12.98, a P/E/G ratio of 1.29 and a beta of 0.68. Acadia Healthcare has a one year low of $24.27 and a one year high of $45.35. The stock’s fifty day moving average is $33.36. The company has a quick ratio of 1.07, a current ratio of 1.09 and a debt-to-equity ratio of 1.53.

Acadia Healthcare (NASDAQ:ACHC) last issued its earnings results on Tuesday, July 30th. The company reported $0.61 EPS for the quarter, topping the consensus estimate of $0.59 by $0.02. The company had revenue of $789.00 million for the quarter, compared to analyst estimates of $795.31 million. Acadia Healthcare had a negative net margin of 6.80% and a positive return on equity of 7.20%. The business’s revenue was up 3.0% on a year-over-year basis. During the same period in the previous year, the firm earned $0.70 EPS. As a group, equities research analysts forecast that Acadia Healthcare will post 2.15 earnings per share for the current year.

Large investors have recently added to or reduced their stakes in the company. Swiss National Bank grew its holdings in shares of Acadia Healthcare by 2.1% during the 2nd quarter. Swiss National Bank now owns 164,168 shares of the company’s stock worth $5,738,000 after purchasing an additional 3,400 shares during the period. Envestnet Asset Management Inc. grew its holdings in shares of Acadia Healthcare by 16.1% during the 2nd quarter. Envestnet Asset Management Inc. now owns 131,743 shares of the company’s stock worth $4,604,000 after purchasing an additional 18,234 shares during the period. Stephens Investment Management Group LLC grew its holdings in shares of Acadia Healthcare by 1.2% during the 2nd quarter. Stephens Investment Management Group LLC now owns 1,142,855 shares of the company’s stock worth $39,943,000 after purchasing an additional 13,695 shares during the period. TD Asset Management Inc. grew its holdings in shares of Acadia Healthcare by 17.8% during the 2nd quarter. TD Asset Management Inc. now owns 323,772 shares of the company’s stock worth $11,316,000 after purchasing an additional 49,000 shares during the period. Finally, Advisor Group Inc. grew its holdings in shares of Acadia Healthcare by 27.1% during the 2nd quarter. Advisor Group Inc. now owns 4,208 shares of the company’s stock worth $146,000 after purchasing an additional 896 shares during the period.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc develops and operates inpatient psychiatric facilities, residential treatment centers, group homes, substance abuse facilities, and outpatient behavioral healthcare facilities to serve the behavioral health and recovery needs of communities in the United States, the United Kingdom, and Puerto Rico.

Further Reading: Why is the ROA ratio important?

Analyst Recommendations for Acadia Healthcare (NASDAQ:ACHC)

Receive News & Ratings for Acadia Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.